JASPER THERAPEUTICS INC JSPR
ASignal's systematic analysis rates JSPR as Bearish.
Reflects the latest available analysis · analyzed Nov 12, 2026
The case on JSPR
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- MACD histogram showing slight positive momentum expansion
- Price near lower Bollinger Band suggesting potential mean reversion
- RSI near neutral, not overbought
- Negative price momentum trend
- MACD below signal line indicating bearish momentum
- Extremely high price-to-book ratio (295.2x)
- Zero profitability margins across all metrics
- Lack of revenue and earnings growth data
- Very limited news coverage (only 2 sources)
See the full verdict on JSPR
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes JSPR
Most investors never get a second opinion, let alone several. ASignal runs JSPR past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.